Fmoc-L-Norleucine

Fmoc-L-Norleucine is an Fmoc-protected L-norleucine amino acid bearing a linear aliphatic side chain with a stereogenic alpha carbon, making it a defined chiral building block for peptide chemistry. The molecule contains a fluorenylmethoxycarbonyl (Fmoc) group on the amino functionality, a free carboxylate (typically handled as the activated acid in coupling chemistry), and a hydrophobic methylene-rich side chain that mimics norleucine residues in peptide and peptidomimetic scaffolds. The Fmoc carbamate is stable under base-compatible conditions used for solid-phase synthesis yet can be removed under standard deprotection conditions to regenerate the nucleophilic amine for sequential coupling. The combination of a protected alpha-amino group and an aliphatic side chain supports controlled peptide assembly, side-chain functional derivatization, and downstream conversion into synthetic intermediates for applied chemical research and manufacturing.

1. Peptide Synthesis

Fmoc-L-Norleucine is used in peptide synthesis workflows where Fmoc-based N-protection enables stepwise amide bond formation with controlled stereochemical integrity of the L-alpha center. The Fmoc carbamate protects the amino group during coupling and washing cycles, while the carboxylic acid functionality participates as the acyl component after activation, supporting compatibility with common peptide coupling chemistries. The norleucine side chain provides a hydrophobic, non-aromatic, methylene-rich residue that can be incorporated to tune folding propensity, membrane affinity, and proteolytic stability in peptide analogs. Fmoc-L-Norleucine therefore serves as a practical peptide building block for generating defined sequences and for producing research-grade peptide materials that require a linear side-chain amino acid.

2. Peptidomimetics And SAR Studies

Fmoc-L-Norleucine is applied to peptidomimetic construction and structure-activity relationship studies where replacing or varying side-chain length and hydrophobic character is used to probe molecular recognition. The linear aliphatic side chain can be positioned within bioactive peptide scaffolds to modulate conformational preferences and binding interfaces without introducing aromatic or heteroatom-containing substituents. Fmoc protection supports rapid assembly of analog libraries by enabling parallel synthesis of sequence variants that differ at the norleucine position. The resulting norleucine-containing peptide analogs can be carried forward into SAR mapping, fragment-based optimization, and comparative studies of how side-chain topology influences physicochemical behavior.

3. Side-Chain Functionalization

Fmoc-L-Norleucine is suitable for amino acid modification strategies aimed at converting the methylene-rich side chain into functional handles for conjugation or further synthetic elaboration. The protected amino group allows selective transformations at the side chain or carboxyl-derived intermediates while maintaining compatibility with peptide-oriented protecting-group logic. The norleucine framework can be routed into derivatives such as side-chain oxidized, halogenated, or functional-group appended analogs that retain the stereogenic alpha center for consistent downstream incorporation. Fmoc-L-Norleucine thus functions as a chiral starting point for generating functionalized amino acid derivatives and for preparing intermediates used in chemical biology probes and material-scaffold conjugates.

4. Protein Engineering

Fmoc-L-Norleucine is employed in protein engineering and chemically defined protein segment synthesis where noncanonical hydrophobic residues are introduced to study sequence-dependent structure and interaction patterns. The Fmoc-protected format supports incorporation into peptide fragments that can be assembled into larger constructs, including engineered domains and stapled or cyclized peptide segments used as surrogates for protein motifs. The L stereochemistry and the absence of heteroatoms in the side chain help isolate the effects of hydrophobic packing and chain length on local conformations. The resulting norleucine-containing segments can be used to support mechanistic investigations, binding interface mapping, and protein-peptide interaction studies in applied biochemical research.

5. Pharmaceutical Intermediate Preparation

Fmoc-L-Norleucine is relevant to pharmaceutical intermediate preparation and fine chemical synthesis because it provides a protected, chiral amino acid building block compatible with industrial peptide-manufacturing logic. The Fmoc carbamate offers a robust protection strategy during multistep synthesis, while the carboxyl functionality can be converted into activated intermediates for incorporation into larger molecules. The linear hydrophobic side chain can be used to construct peptide-like intermediates, peptidomimetic fragments, or scaffold components where controlled hydrophobicity is required for downstream processing and formulation studies. Fmoc-L-Norleucine therefore supports manufacturing routes that rely on stereochemically defined amino acid derivatives and scalable solid-phase or solution-phase peptide assembly steps.

6. Analytical Research Standards

Fmoc-L-Norleucine is used in analytical research as a reference material and internal standard precursor for method development targeting peptide and amino acid derivatives. The defined Fmoc protection and L stereochemistry enable reproducible handling during derivatization, peptide coupling, and deprotection workflows that are common in LC-MS and related analytical pipelines. The norleucine side chain contributes a characteristic hydrophobic signature that can aid in distinguishing norleucine-containing peptides or fragments from closely related amino acid analogs. Fmoc-L-Norleucine can be employed to prepare defined analytical standards, calibration components, and characterization samples that support accurate monitoring of peptide synthesis outcomes and impurity profiling.

1. Cationic cell-penetrating peptides are potent furin inhibitors

2. Immune responses to peptides containing homocitrulline or citrulline in the DR4-transgenic mouse model of rheumatoid arthritis

3. Identification, Localization in the Central Nervous System and Novel Myostimulatory Effect of Allatostatins in Tenebrio molitor Beetle

4. An interdomain binding site on HIV-1 Nef interacts with PACS-1 and PACS-2 on endosomes to down-regulate MHC-I

5. Olfactory receptor based piezoelectric biosensors for detection of alcohols related to food safety applications